Document is current
Any future updates will be listed below
-
Authors
Olsen, Jonas http://orcid.org/0000-0003-1086-6265
Gaetti, Giovanni http://orcid.org/0000-0001-5464-5822
Grandahl, Kasper http://orcid.org/0000-0003-3593-0155
Jemec, Gregor Borut Ernst http://orcid.org/0000-0002-0712-2540
- License Information
-
More Information
Article History
Received: 6 October 2020
Revised: 29 April 2021
Accepted: 22 May 2021
First Online: 10 June 2021
Declarations
:
: GBE Jemec has received honoraria from AbbVie, Chemocentryx, Coloplast, Incyte, Inflarx, Novartis, Pierre Fabre and UCB for participation on advisory boards, and grants from Abbvie, Astra-Zeneca, Inflarx, Janssen-Cilag, Leo Pharma, Novartis, Regeneron and Sanofi, for participation as an investigator, and received speaker honoraria from AbbVie, Boehringer-Ingelheim, Galderma, MSD and Novartis. He has also received unrestricted departmental grants from Leo Pharma and Novartis. The remaining authors have no conflicts of interest to declare.
: As declared above this observational study involving human participants is in compliance with ethical standards. Informed consent was obtained and potential conflicts of interests have been disclosed.
: This observational study was approved by the Regional Science Ethics committee of Zealand on the 15th of December 2015, study ID SJ-509. The study was performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.
: Informed consent was obtained from all individual participants included in the study.
: Not applicable.
